Indication
Skin and skin structure Streptococcus agalactiae infection
A skin and skin structure *Streptococcus agalactiae* infection is a bacterial dermatologic and subcutaneous soft-tissue infection caused by *Streptococcus agalactiae* (group B Streptococcus). Read more about Skin and skin structure Streptococcus agalactiae infection
73 drugs 54 manufacturers
Drugs that treat it
Common Skin and skin structure Streptococcus agalactiae infection therapies.
CEFOTETAN & DEXTROSE (cefotetan disodium in iso-osmotic dextrose)
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
AZITHROMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA skin and skin structure *Streptococcus agalactiae* infection is a bacterial dermatologic and subcutaneous soft-tissue infection caused by *Streptococcus agalactiae* (group B Streptococcus).
Although this gram-positive pathogen commonly colonizes the human gastrointestinal and genitourinary tracts, it can invade breached epithelial barriers to cause clinical syndromes such as cellulitis, erysipelas, abscesses, infected diabetic ulcers, wound infections, and occasionally deeper necrotizing fasciitis.
The condition disproportionately affects elderly individuals, postpartum women, and adults with predisposing chronic conditions such as diabetes mellitus, peripheral vascular disease, venous stasis, or immunocompromise.
Pathophysiologically, localized bacterial proliferation and extracellular virulence factors provoke intense tissue inflammation and vascular leakage, typically presenting with acute erythema, warmth, pain, edema, and a risk of secondary bacteremia or systemic illness.
- nih.gov
A skin and skin structure *Streptococcus agalactiae* infection is a bacterial dermatologic and subcutaneous soft-tissue infection caused by *Streptococcus agalactiae* (group B Streptococcus) Although this gram-positive pathogen commonly colonizes the human gastrointestinal and genitourinary tracts, it can invade breached epithelial barriers to cause clinical syndromes such as cellulitis, erysipelas, abscesses, infected diabetic ulcers, wound infections, and occasionally deeper necrotizing fascii...
- wikipedia.org
A skin and skin structure *Streptococcus agalactiae* infection is a bacterial dermatologic and subcutaneous soft-tissue infection caused by *Streptococcus agalactiae* (group B Streptococcus)
- nih.gov
Although this gram-positive pathogen commonly colonizes the human gastrointestinal and genitourinary tracts, it can invade breached epithelial barriers to cause clinical syndromes such as cellulitis, erysipelas, abscesses, infected diabetic ulcers, wound infections, and occasionally deeper necrotizing fasciitis
- cdc.gov
The condition disproportionately affects elderly individuals, postpartum women, and adults with predisposing chronic conditions such as diabetes mellitus, peripheral vascular disease, venous stasis, or immunocompromise
- nih.gov
The condition disproportionately affects elderly individuals, postpartum women, and adults with predisposing chronic conditions such as diabetes mellitus, peripheral vascular disease, venous stasis, or immunocompromise
- nih.gov
Pathophysiologically, localized bacterial proliferation and extracellular virulence factors provoke intense tissue inflammation and vascular leakage, typically presenting with acute erythema, warmth, pain, edema, and a risk of secondary bacteremia or systemic illness
Personalize your experience
Follow Skin and skin structure Streptococcus agalactiae infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.